纵横研报
Ticker Detail

600161.SHG

¥12.59+2.19% 天坛生物 Biotechnology
00Reports China 医疗健康
Beijing Tiantan Biological Products Corp Ltd
医疗健康 · 生物科技

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.

MARKET 市值 23.89B CNY PE 24.7x Fwd 17.7x 52W ¥11.12 – ¥22.08 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 营收 YoY -13.4% ROE 8.8% 营业利润率 19.3% 净利润率 16.2%
ANALYST 股息率 1.66%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制